Reaction
Gallbladder Cancer reporting signals
As of the last recalculation, Gallbladder Cancer appears in 1,456 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is RANITIDINE HYDROCHLORIDE (PRR 39.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranitidine Hydrochloride | 136 | 39.4 | 39.5 |
| Ranitidine | 373 | 35.7 | 35.8 |
| Doxepin | 8 | 11.3 | 11.3 |
| Rotigotine | 10 | 9.9 | 10.0 |
| Levodopa | 8 | 9.5 | 9.5 |
| Durvalumab | 13 | 9.2 | 9.2 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 14 | 8.6 | 8.6 |
| Medroxyprogesterone Acetate | 27 | 7.9 | 7.9 |
| Velpatasvir And Sofosbuvir | 4 | 4.5 | 4.5 |